Press Room

A federal judge has blocked a rule change that would have expanded the availability of Association Health Plans (AHP). These plans often leave beneficiaries underinsured because they are exempt from covering the essential health benefits required under the health care law, including prescription drug coverage, and can also cap coverage based on the number of hospital days or cost of services and cover less than 60 percent of a patient’s medical costs. 

A new nationwide survey of cancer patients, caregivers and doctors details the negative effects insurance utilization management policies in private insurance have had on patient care and what those policies could mean should proposed changes to Medicare’s Part D’s “six protected classes” prescription drug coverage policy go into effect.

Washington, D.C. – Legislation introduced today by Rep. Elijah Cummings (D-Md.) aims to decrease disparities in access to cancer clinical trials that persist within certain underrepresented communities. The Henrietta Lacks Enhancing Cancer Research Act of 2019 would direct the U.S.

Today the House Energy and Commerce Subcommittee on Health is considering a series of bills that would stabilize and strengthen the health insurance market and decrease the number of uninsured by improving the ability of people with pre-existing conditions to obtain and afford comprehensive health coverage.

Washington, D.C.

Washington, D.C. – March 27, 2019 – A proposed rule issued by the U.S. Food and Drug Administration (FDA) today would modernize mammography quality standards and address breast density reporting to patients and their health care providers.

ACS CAN is concerned about a recent administration announcement affirming a district court decision to overturn the health care law. 

Washington, D.C. – The U.S.

Washington, D.C. – The White House has announced its intention to appoint Dr. Ned Sharpless, current director of the National Cancer Institute (NCI), as acting commissioner of the Food and Drug Administration (FDA). Dr.

The administration released its FY20 budget today including a $4.7 billion cut for medical research at the National Institutes of Health (NIH) including a nearly $900 million cut for the National Cancer Institute (NCI).